Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020.
Usui J, Kawashima S, Sada KE, Miyawaki Y, Nakazawa D, Itabashi M, Endo S, Endo T, Oda T, Ohya M, Kitagawa K, Nagasawa T, Hirahashi J, Hiromura K, Kawaguchi T, Takayasu M, Tsuboi N, Hirayama K, Muso E, Yumura W, Kaname S, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for Rapidly Progressive Glomerulonephritis 2020. Usui J, et al. Among authors: kitagawa k. Clin Exp Nephrol. 2021 Dec;25(12):1286-1291. doi: 10.1007/s10157-021-02096-7. Epub 2021 Sep 26. Clin Exp Nephrol. 2021. PMID: 34564791 No abstract available.
CCR2 signaling contributes to ischemia-reperfusion injury in kidney.
Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Asano M, Wang H, Matsushima K, Takeya M, Kuziel WA, Mukaida N, Yokoyama H. Furuichi K, et al. Among authors: kitagawa k. J Am Soc Nephrol. 2003 Oct;14(10):2503-15. doi: 10.1097/01.asn.0000089563.63641.a8. J Am Soc Nephrol. 2003. PMID: 14514728
Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.
Wada T, Furuichi K, Sakai N, Iwata Y, Kitagawa K, Ishida Y, Kondo T, Hashimoto H, Ishiwata Y, Mukaida N, Tomosugi N, Matsushima K, Egashira K, Yokoyama H. Wada T, et al. Among authors: kitagawa k. J Am Soc Nephrol. 2004 Apr;15(4):940-8. doi: 10.1097/01.asn.0000120371.09769.80. J Am Soc Nephrol. 2004. PMID: 15034096
Blockade of CCR2 ameliorates progressive fibrosis in kidney.
Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M, Takeya M, Kuziel WA, Matsushima K, Mukaida N, Yokoyama H. Kitagawa K, et al. Am J Pathol. 2004 Jul;165(1):237-46. doi: 10.1016/S0002-9440(10)63292-0. Am J Pathol. 2004. PMID: 15215179 Free PMC article.
The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese.
Yokoyama H, Wada T, Hara A, Yamahana J, Nakaya I, Kobayashi M, Kitagawa K, Kokubo S, Iwata Y, Yoshimoto K, Shimizu K, Sakai N, Furuichi K; Kanazawa Study Group for Renal Diseases and Hypertension. Yokoyama H, et al. Among authors: kitagawa k. Kidney Int. 2004 Dec;66(6):2382-8. doi: 10.1111/j.1523-1755.2004.66027.x. Kidney Int. 2004. PMID: 15569330 Free article.
Blockade of IP-10/CXCR3 promotes progressive renal fibrosis.
Nakaya I, Wada T, Furuichi K, Sakai N, Kitagawa K, Yokoyama H, Ishida Y, Kondo T, Sugaya T, Kawachi H, Shimizu F, Narumi S, Haino M, Gerard C, Matsushima K, Kaneko S. Nakaya I, et al. Among authors: kitagawa k. Nephron Exp Nephrol. 2007;107(1):e12-21. doi: 10.1159/000106505. Epub 2007 Jul 18. Nephron Exp Nephrol. 2007. PMID: 17671396
Involvement of CD11b+ GR-1 low cells in autoimmune disorder in MRL-Fas lpr mouse.
Iwata Y, Furuichi K, Kitagawa K, Hara A, Okumura T, Kokubo S, Shimizu K, Sakai N, Sagara A, Kurokawa Y, Ueha S, Matsushima K, Kaneko S, Wada T. Iwata Y, et al. Among authors: kitagawa k. Clin Exp Nephrol. 2010 Oct;14(5):411-7. doi: 10.1007/s10157-010-0309-9. Epub 2010 Jul 23. Clin Exp Nephrol. 2010. PMID: 20652350
1,472 results